FORWARD PHARMA A/S: Financial statements 2016
CVR: 28865880
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2016. In 2016, the company reported a net result of USD 2,032,000 compared with USD -51,065,000 the year before. Equity in the 2016 report amounted to USD 189,657,000. The solvency ratio was 95.2%.
- Profit/Loss
- USD 2,032,000
- Equity
- USD 189,657,000
- Total Assets
- USD 199,203,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | 2 mio. USD | 189.7 mio. USD | - |
| 2015 | - | - | -51.1 mio. USD | 176.7 mio. USD | - |
| 2014 | - | - | -13.7 mio. USD | 238 mio. USD | - |
| 2012 | - | -11 mio. | 22.4 mio. | 50.4 mio. | - |
Find more companies like FORWARD PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
FORWARD PHARMA A/S has published its annual report for 2015. The net result was DKK -51,065,000.
As of May 6, 2016, Karen Lesley Smith has joined the board of directors of FORWARD PHARMA A/S.
As of May 6, 2016, Duncan Moore has joined the board of directors of FORWARD PHARMA A/S.
As of May 6, 2016, John Kevin Buchi has left the board of directors of FORWARD PHARMA A/S.
As of March 1, 2016, Rupert Sandbrink is registered as director of FORWARD PHARMA A/S.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.